Gripwise® Versus JAMAR® (HANDGAGES)

Caen University Hospital

Status: Completed

Conditions: Age-Related Sarcopenia

Study type: Observational

Funder types: Other

Identifiers

NCT05060874

2021-A00927-34

Details and patient eligibility

About

It is recommended to screen ageing patients for sarcopenia, due to the increased risk of morbimortality if detected positive. According to the consensus of the European Working Group on Sarcopenia in Older People, the diagnosis of sarcopenia is based, among other things, on grip strength measurement.

Our study will compare the performance of the new GRIPWISE digital device with the mechanical dynamometer JAMAR, the gold standard currently used to assess the grip strength. We propose to evaluate it in an elderly hospitalized population where the prevalence of sarcopenia is likely to be high due to the high prevalence of various chronic illness, notably oncological and cardiological ones.

This cross-sectional study will include 348 patients.

Enrollment: 348 patients

Sex: All

Ages: 65+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• men and women aged 65 or over
• affiliated to a health insurance
• Francophone.

Exclusion criteria

• • refusal to participate
• unable to communicate
• unable to use both hands (dominant and non-dominant)

Trial design

348 participants in 1 patient group

single group

Description:

gripwise or jamar will be randomly assessed first